Skip to content
Clinical Trials – home
Cytokinetics Inc.
Sponsor

Cytokinetics Inc.

United States 350 Oyster Point Boulevard, 94080-1912, United States

About the sponsor

Clinical research in hypertrophic cardiomyopathy includes both obstructive and non-obstructive forms, with attention to symptomatic HCM and left ventricular outflow tract obstruction. The studies focus on functional status, exercise capacity, and cardiac symptom burden.

  • Symptomatic obstructive hypertrophic cardiomyopathy
  • Symptomatic non-obstructive hypertrophic cardiomyopathy
  • Left ventricular outflow tract obstruction
  • Exercise capacity

Work in this area also includes pediatric hypertrophic cardiomyopathy, reflecting interest across age groups and disease presentations.

About Specializations

Cytokinetics Inc. runs clinical trials in conditions such as Hypertrophic cardiomyopathy, Heart failure with reduced ejection fraction, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

5 clinical trials

Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:OMECAMTIV MECARBIL
  • Sponsor:Cytokinetics Inc.
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Aficamten
  • Sponsor:Cytokinetics Inc.
Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Aficamten
  • Sponsor:Cytokinetics Inc.
Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Aficamten
  • Sponsor:Cytokinetics Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.